Compounding Pharmacy · , · Retail
Walmart Pharmacy Review
Walmart Pharmacy is a national retail pharmacy that dispenses FDA-approved branded GLP-1 medications (not compounded). Through Novo Nordisk's self-pay program it offers branded semaglutide (Wegovy/Ozempic) at self-pay prices roughly $149/month for oral tablets and about $349/month for injections, and through a partnership with Eli Lilly it dispenses single-dose vials of Zepbound (tirzepatide) at Walmart pharmacies nationwide or via home delivery. Walmart also runs a GLP-1 care platform with virtual care and nutrition support through its Better Care Services.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
About this pharmacy
Walmart Pharmacy is a national retail pharmacy that dispenses FDA-approved branded GLP-1 medications (not compounded). Through Novo Nordisk's self-pay program it offers branded semaglutide (Wegovy/Ozempic) at self-pay prices roughly $149/month for oral tablets and about $349/month for injections, and through a partnership with Eli Lilly it dispenses single-dose vials of Zepbound (tirzepatide) at Walmart pharmacies nationwide or via home delivery. Walmart also runs a GLP-1 care platform with virtual care and nutrition support through its Better Care Services.
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
We have not verified any third-party accreditations for this pharmacy beyond its state pharmacy license.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed (0)
Regulatory Actions
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
High confidence · Last verified 2026-06-04 via manual · How we verify provider data
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology — as of June 2026
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.